B | HR | HR (95% CI) | P Value | ||
---|---|---|---|---|---|
Sex | Male | 0.438 | 1.549 | 1.091 – 2.198 | 0.014 |
Female | |||||
Age at exposure time | 0.075 | 1.078 | 1.066 – 1.086 | 0.000 | |
Severity of late complications in lung | No symptom | ||||
Mild | - 0.077 | 0.925 | 0.625 – 1.369 | 0.699 | |
Moderate | 0.556 | 1.744 | 1.093 – 2.779 | 0.019 | |
Severe | 1.954 | 7.057 | 3.706 – 13.437 | 0.000 | |
Severity of late complications in skin | No symptom | ||||
Mild | 0.275 | 1.316 | 0.897 – 1.929 | 0.160 | |
Moderate | 0.391 | 1.479 | 0.688 – 3.179 | 0.316 | |
Severe | 0.332 | 1.393 | 0.194 – 9.984 | 0.741 | |
Severity of late complications in eye | No symptom | ||||
Mild | 0.260 | 1.297 | 0.868 – 1.937 | 0.203 | |
Moderate | -0.168 | 0.846 | 0.118 – 6.054 | 0.867 | |
Severe | - | - | - | - | |
Evacuation and hospital admission status | EA | ||||
NEA | -0.666 | 0.514 | 0.372 – 0.708 | 0.000 |